Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Shapermint Completes Five-Month, Three-Episode Partnership with SHERRI, Celebrating Confidence and Comfort Through Mother's Day
-
PRE ANNOUNCEMENT OF CERTIFICATE AUCTION TENDER
-
ViaNautis Bio to present its targeted polyNaut® nanovesicles (tPNVs) for the generation of in vivo CAR-T therapies at ASGCT Annual Meeting
-
Temenos Launches Embedded AI Capabilities to Help Banks Move Faster, Stay in Control, and Create Better Experiences
-
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
-
Valeo - Voting rights - April 2026
-
Replacement in bonds for new lending - Nykredit Realkredit A/S
-
Apollo Funds Complete Acquisition of Prosol Group
-
Ashley Graham to Spotlight the Power of Authentic Partnerships as a Keynote Speaker at Licensing Expo 2026
-
Telko to reorganize its operations into two business units
-
LinkedIn partners with the Digital Vending Machine® from Bango to expand Premium reach through bundling
-
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.
-
The decision of the management company of INVL Technology on the purchase of own shares
-
Suominen Corporation’s Interim Report for January 1 – March 31, 2026: Profitability improvement program underway
-
Michelin: Disclosure of trading in own shares - May 7th, 2026
-
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
-
BAE Systems – Trading update
-
Financial Calendar 2026 - update
-
Shell announces commencement of a share buyback programme
-
Shell announces commencement of a share buyback programme
-
Shell plc First Quarter 2026 Interim Dividend
-
Shell plc publishes first quarter 2026 press release
-
Shell Plc 1st Quarter 2026 Unaudited Results
-
Interim Report Q1 2026
-
Solar A/S: Nr. 11 2026 Q1 results at the lower end of our expected range
-
Shell Plc 1st Quarter 2026 Unaudited Results
-
Extension of the powers of a Member of the Management Board of AS Merko Ehitus
-
Harvia’s Interim report 1 January – 31 March 2026
-
Preliminary Results for the twelve months ended 31 January 2026
-
Vopak reaches agreement with Green Energy Storage (GES) for majority stake in GES to accelerate large-scale battery storage in the Netherlands
-
Solid first quarter results despite lower production
-
NBPE Announces Transaction in Own Shares
-
Trading Statement
-
Transaction in Own Shares
-
Holding(s) in Company
-
Alm. Brand A/S – Launch of new share buyback programme in accordance with the ‘Safe Harbour’ rules
-
Report on Payments to Governments
-
CMB.TECH announces Q1 2026 results on 19/05/2026
-
Oma Savings Bank Plc's Interim Report 1.1.-31.3.2026: The volume of new loans began to increase – capital adequacy continued to strengthen – the comparable profit before tax for the first quarter
-
David Hellemann, Group Managing Director, has been appointed Deputy Group Chief Executive of the Nykredit Group
-
Interim Reports Q1 2026 - Nykredit Realkredit Group
-
The Feronord consortium has won the OL32 Skavsta contract, part of the East Link rail project south of Stockholm, Sweden
-
Bouygues: Strong first-quarter 2026 Group results, outlook for the full-year confirmed
-
SUSTAINED POSITIVE TRADING MOMENTUM
-
Navatar Brings AI-Powered Corporate Finance Advisory CRM to Salesforce for Investment Banks and Consulting Firms
-
Iveco Group 2026 First Quarter Results
-
Zealand Pharma - Execution framework for share buy-back program
-
Pharming Group announces presentations at CIS 2026 Annual Meeting, including leniolisib pediatric data in APDS and clinical experience in CVID and related disorders
-
Zealand Pharma - Execution framework for share buy-back program
-
EfTEN United Property Fund unaudited financial results for the 1st quarter of 2026
